Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Sleep apnea (SA), characterized by recurrent apnea and hypopnea during sleep, includes central and obstructive subtypes. The comorbidity of chronic kidney disease (CKD) and sleep apnea is highly prevalent in clinical practice. While observational studies suggest an association between SA and kidney dysfunction, the causal relationship and underlying mechanisms remain unclear. This study conducted a bidirectional Mendelian randomization (MR) analysis to investigate bidirectional causal effects between SA and kidney function indicators.
We performed bidirectional univariate MR analyses using genetic instruments. The data of individuals with SA data (21,232 cases/604,917 controls) were obtained from UK Biobank and FinnGen consortium. Genome-wide association study summary statistics for kidney function biomarkers were obtained from the Chronic Kidney Disease Genetics Consortium, including blood urea nitrogen (BUN, N=852,678), creatinine-based estimated glomerular filtration rate (eGFRcrea, N=1,004,040), cystatin C-based eGFR (eGFRcys, N=460,826), urinary albumin-to-creatinine ratio (UACR, N=547,361), and serum urate (N=288,649). Inverse-variance weighted method was used as primary analysis with supplementary MR methods.
The forward MR analysis demonstrated significant causal effects of kidney function on SA: eGFRcrea (OR=0.516, 95% CI: 0.358-0.744) and eGFRcys (OR=0.786, 95% CI: 0.647-0.955) showed protective effects, while BUN showed risk-increasing effect (OR=1.689, 95% CI: 1.269-2.248). The reverse MR analysis indicated SA significantly increased urate levels (OR=1.108, 95% CI: 1.037-1.184). No significant causal relationship was found between UACR and SA in either direction.
This MR study provides evidence for bidirectional causal relationships between sleep apnea and kidney function. Impaired glomerular filtration rate and elevated BUN appear to increase SA risk, while SA contributes to elevated urate levels. These findings suggest potential pathophysiological interactions between respiratory dysfunction during sleep and renal impairment that warrant further investigation.